Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

A Method For Generation Of Cells Expressing Self-replicating Norovirus RNA (norovirus "replicons")

  • Read more about A Method For Generation Of Cells Expressing Self-replicating Norovirus RNA (norovirus "replicons")
US Application 60/669,817
Filed on 2005-04-08

Monoclonal Antibodies that Bind or Neutralize Dengue Virus

  • Read more about Monoclonal Antibodies that Bind or Neutralize Dengue Virus
US Application 60/624,261
Filed on 2004-11-01

Isolation And Characterization Of Chimpanzee Monoclonal Antibodies Capable Of Efficiently Neutralizing Dengue Type 1,2,3 And 4 Viruses

  • Read more about Isolation And Characterization Of Chimpanzee Monoclonal Antibodies Capable Of Efficiently Neutralizing Dengue Type 1,2,3 And 4 Viruses
US Application 60/574,492
Filed on 2004-05-26

Optimized Vaccines to Provide Protection Against Ebola and Other Viruses

  • Read more about Optimized Vaccines to Provide Protection Against Ebola and Other Viruses
US Application 60/677,606
Filed on 2005-05-03

Treatment and prevention of IBD using Mutant and Chimeric Il-13 Molecules

  • Read more about Treatment and prevention of IBD using Mutant and Chimeric Il-13 Molecules
US Application 60/671,624
Filed on 2005-04-15

Recombinant MVA Viruses Expressing Clade A/G and Clade B Modified HIV Env, Gag, and POL Genes

  • Read more about Recombinant MVA Viruses Expressing Clade A/G and Clade B Modified HIV Env, Gag, and POL Genes
US Application 60/604,918
Filed on 2004-08-27

Structured-Based Enchancement of CD4-Molecular Mimicry Leads to Increase Breadth of HIV Neutralization

  • Read more about Structured-Based Enchancement of CD4-Molecular Mimicry Leads to Increase Breadth of HIV Neutralization
US Application 60/623,762
Filed on 2004-10-29

Development Of The Rotavirus NSP2 Octamer As An Epitope-Mounting Platform

  • Read more about Development Of The Rotavirus NSP2 Octamer As An Epitope-Mounting Platform
US Application 60/633,036
Filed on 2004-12-03

Optimized Vaccines To Provide Protection Against Ebola And Other Viruses

  • Read more about Optimized Vaccines To Provide Protection Against Ebola And Other Viruses
US Application 60/613,883
Filed on 2004-09-27

ATTENUATED HUMAN PARAINFLUENZA VIRUS, METHODS AND USES THEREOF

  • Read more about ATTENUATED HUMAN PARAINFLUENZA VIRUS, METHODS AND USES THEREOF
US Application 60/643,310
Filed on 2005-01-12

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 91
  • Page 92
  • Page 93
  • Page 94
  • Page 95
  • Page 96
  • Page 97
  • Page 98
  • Page 99
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health